Marchex Tumbles 4% on Weak Outlook Despite Archenia Acquisition
The conversational analytics firm missed Q3 revenue targets, with the news overshadowing a strategic deal aimed at accelerating AI-driven growth in 2026.
Shares of Marchex Inc. (NASDAQ: MCHX) fell nearly 4% in trading Thursday after the conversational intelligence company reported third-quarter revenue that missed analyst estimates and offered a weaker near-term outlook, souring investor sentiment on its simultaneous announcement of a significant acquisition.
The Seattle-based firm saw its stock close down 3.75% at $1.54, as investors weighed a strategic bet on future growth against immediate financial headwinds. Marchex reported Q3 revenue of $11.5 million, a decline from $12.6 million in the same period last year and short of the $11.9 million consensus estimate. The company posted a net loss of $1.0 million, or $0.02 per share, though its adjusted non-GAAP earnings per share were flat at $0.00, beating estimates of a one-cent loss.
While the company’s management guided towards sequentially lower revenue and Adjusted EBITDA for the next period, it simultaneously unveiled an agreement in principle to acquire Archenia, Inc., a performance-based customer acquisition company. Marchex framed the deal as a cornerstone of its strategy to build a vertically-focused, AI-driven platform. The acquisition consideration consists of a $10 million convertible promissory note and a potential earn-out of up to 4 million shares.
Archenia specializes in using AI signals and natural language analytics to convert consumer intent into verified outcomes, such as sales and appointments. Marchex executives believe the combination will create a powerful platform that capitalizes on the industry’s shift toward new Pay-Per-Event advertising models.
Despite the revenue miss, Marchex leadership projected confidence in the company's trajectory, particularly with the integration of Archenia. “The third quarter marked continued progress in launching new products and achieving the highest sales bookings of the year,” said Troy Hartless, President of Marchex, in a statement. He highlighted a 50% sequential improvement in quarterly Adjusted EBITDA, net of reorganization costs, to $1.1 million. “Based on accelerating sales bookings, Marchex anticipates increased and sustainable sales growth into 2026,” Hartless added.
Following the proposed acquisition, the company is targeting 10% revenue growth and an adjusted EBITDA margin of at least 10% for the full year 2026. The combined entity is projected to have a quarterly revenue run rate of approximately $15 million, a significant step up for the company, which currently has a market capitalization of around $70 million.
However, the path to finalizing the acquisition contains several hurdles. The transaction is currently an Agreement in Principle and remains contingent upon Archenia providing audited financial statements, the receipt of a customary fairness opinion, and, crucially, approval from a majority of Marchex’s disinterested stockholders, according to company filings. The deal is not expected to close until the first half of 2026.
The market's reaction suggests investors are focusing more on the immediate challenges of declining revenue and a soft forecast than the potential long-term synergies of the Archenia deal. The announcement presents a complex picture of a company navigating short-term operational struggles while making a decisive, but not yet certain, pivot toward a higher-growth, AI-powered future.